• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌干细胞与免疫系统:促进、逃避与治疗

Breast cancer stem cells and the immune system: promotion, evasion and therapy.

作者信息

Boyle Sarah T, Kochetkova Marina

机构信息

School of Molecular and Biomedical Science, University of Adelaide, Adelaide, South Australia, Australia.

出版信息

J Mammary Gland Biol Neoplasia. 2014 Jul;19(2):203-11. doi: 10.1007/s10911-014-9323-y. Epub 2014 Jul 6.

DOI:10.1007/s10911-014-9323-y
PMID:24997735
Abstract

Cancer stem cells are believed to be a subset of heterogeneous tumour cells responsible for tumour initiation, growth, local invasion, and metastasis. In breast cancer, numerous factors have been implicated in regulation of cancer stem cells, but there is still a paucity of information regarding precise molecular and cellular mechanisms guiding their pathobiology. Components of both the adaptive and the innate immune system have been shown to play a crucial role in supporting breast cancer growth and spread, and recently some immune mediators, both molecules and cells, have been reported to influence breast cancer stem cell biology. This review summarises a small, pioneering body of evidence for the potentially important function of the "immuniche" in maintaining and supporting breast cancer stem cells.

摘要

癌症干细胞被认为是异质性肿瘤细胞的一个亚群,负责肿瘤的起始、生长、局部侵袭和转移。在乳腺癌中,许多因素与癌症干细胞的调控有关,但关于指导其病理生物学的精确分子和细胞机制,仍缺乏相关信息。适应性免疫系统和先天性免疫系统的组成部分均已被证明在支持乳腺癌的生长和扩散中发挥关键作用,最近有报道称一些免疫介质,包括分子和细胞,会影响乳腺癌干细胞生物学。这篇综述总结了一小部分具有开创性的证据,证明“免疫小生境”在维持和支持乳腺癌干细胞方面可能具有重要功能。

相似文献

1
Breast cancer stem cells and the immune system: promotion, evasion and therapy.乳腺癌干细胞与免疫系统:促进、逃避与治疗
J Mammary Gland Biol Neoplasia. 2014 Jul;19(2):203-11. doi: 10.1007/s10911-014-9323-y. Epub 2014 Jul 6.
2
Stromal fibroblasts and the immune microenvironment: partners in mammary gland biology and pathology?基质成纤维细胞与免疫微环境:乳腺生物学和病理学中的伙伴?
J Mammary Gland Biol Neoplasia. 2014 Jul;19(2):169-82. doi: 10.1007/s10911-014-9326-8. Epub 2014 Jul 2.
3
Epigenetic Silencing of TAP1 in Aldefluor Breast Cancer Stem Cells Contributes to Their Enhanced Immune Evasion.Aldefluor 乳腺癌干细胞中 TAP1 的表观遗传沉默导致其免疫逃逸增强。
Stem Cells. 2018 May;36(5):641-654. doi: 10.1002/stem.2780. Epub 2018 Jan 30.
4
Can breast cancer stem cells evade the immune system?乳腺癌干细胞能否逃避免疫系统?
Curr Med Chem. 2012;19(35):6036-49. doi: 10.2174/092986712804485863.
5
The intersection of cancer, cancer stem cells, and the immune system: therapeutic opportunities.癌症、癌症干细胞与免疫系统的交叉点:治疗机遇
Neuro Oncol. 2016 Feb;18(2):153-9. doi: 10.1093/neuonc/nov157. Epub 2015 Aug 11.
6
Adaptive immune responses associated with breast cancer relapse.与乳腺癌复发相关的适应性免疫反应。
Arch Immunol Ther Exp (Warsz). 2012 Oct;60(5):345-50. doi: 10.1007/s00005-012-0185-y. Epub 2012 Aug 22.
7
Hormonal regulation of the immune microenvironment in the mammary gland.乳腺中免疫微环境的激素调节
J Mammary Gland Biol Neoplasia. 2014 Jul;19(2):229-39. doi: 10.1007/s10911-014-9324-x. Epub 2014 Jul 4.
8
The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy.作为乳腺癌免疫治疗靶点的先天性和适应性浸润免疫系统。
Endocr Relat Cancer. 2017 Apr;24(4):R123-R144. doi: 10.1530/ERC-16-0404. Epub 2017 Feb 13.
9
LGR4 modulates breast cancer initiation, metastasis, and cancer stem cells.LGR4 调节乳腺癌起始、转移和癌症干细胞。
FASEB J. 2018 May;32(5):2422-2437. doi: 10.1096/fj.201700897R. Epub 2017 Dec 21.
10
A role for T-lymphocytes in human breast cancer and in canine mammary tumors.T淋巴细胞在人类乳腺癌和犬乳腺肿瘤中的作用。
Biomed Res Int. 2014;2014:130894. doi: 10.1155/2014/130894. Epub 2014 Feb 2.

引用本文的文献

1
Fate decisions of breast cancer stem cells in cancer progression.癌症进展过程中乳腺癌干细胞的命运决定
Front Oncol. 2022 Aug 15;12:968306. doi: 10.3389/fonc.2022.968306. eCollection 2022.
2
The Tumor Microenvironment as a Driving Force of Breast Cancer Stem Cell Plasticity.肿瘤微环境作为乳腺癌干细胞可塑性的驱动因素
Cancers (Basel). 2020 Dec 21;12(12):3863. doi: 10.3390/cancers12123863.
3
More Than an Adipokine: The Complex Roles of Chemerin Signaling in Cancer.不止是脂肪因子:趋化素信号在癌症中的复杂作用。

本文引用的文献

1
Accumulation of memory precursor CD8 T cells in regressing tumors following combination therapy with vaccine and anti-PD-1 antibody.在联合疫苗和抗 PD-1 抗体治疗后,消退肿瘤中记忆前体 CD8 T 细胞的积累。
Cancer Res. 2014 Jun 1;74(11):2974-85. doi: 10.1158/0008-5472.CAN-13-2564. Epub 2014 Apr 11.
2
The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases.CXCL8/IL-8 趋化因子家族及其在炎症性疾病中的受体。
Expert Rev Clin Immunol. 2014 May;10(5):593-619. doi: 10.1586/1744666X.2014.894886. Epub 2014 Mar 29.
3
Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer.
Int J Mol Sci. 2019 Sep 26;20(19):4778. doi: 10.3390/ijms20194778.
4
Expression of chemerin correlates with a poor prognosis in female breast cancer patients.凯莫瑞蛋白的表达与女性乳腺癌患者的不良预后相关。
Breast Cancer (Dove Med Press). 2018 Oct 23;10:169-176. doi: 10.2147/BCTT.S178181. eCollection 2018.
5
Association between inflammation and cancer stem cell phenotype in breast cancer.乳腺癌中炎症与癌症干细胞表型之间的关联
Oncol Lett. 2018 Feb;15(2):2380-2386. doi: 10.3892/ol.2017.7607. Epub 2017 Dec 13.
6
Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014.早期和局部晚期化生性乳腺癌:监测、流行病学和最终结果(SEER)2010-2014 年按受体状态的表现和生存。
Oncologist. 2018 Apr;23(4):481-488. doi: 10.1634/theoncologist.2017-0398. Epub 2018 Jan 12.
7
Quantitative investigation of MDA-MB-231 breast cancer cell motility: dependence on epidermal growth factor concentration and its gradient.MDA-MB-231乳腺癌细胞运动性的定量研究:对表皮生长因子浓度及其梯度的依赖性。
Mol Biosyst. 2017 Sep 26;13(10):2069-2082. doi: 10.1039/c7mb00390k.
8
Impact of CD44 expression on radiation response for bladder cancer.CD44表达对膀胱癌放射反应的影响。
J Cancer. 2017 Apr 9;8(7):1137-1144. doi: 10.7150/jca.18297. eCollection 2017.
9
Mechanism of immune evasion in breast cancer.乳腺癌的免疫逃逸机制。
Onco Targets Ther. 2017 Mar 14;10:1561-1573. doi: 10.2147/OTT.S126424. eCollection 2017.
10
Exosomes Derived from Breast Cancer Cells, Small Trojan Horses?源自乳腺癌细胞的外泌体,是小型特洛伊木马吗?
J Mammary Gland Biol Neoplasia. 2014 Dec;19(3-4):303-13. doi: 10.1007/s10911-015-9332-5. Epub 2015 Jul 1.
肿瘤浸润 CD8+ 淋巴细胞是乳腺癌原发系统性治疗病理完全缓解的独立预测因素。
Br J Cancer. 2013 Nov 12;109(10):2705-13. doi: 10.1038/bjc.2013.634. Epub 2013 Oct 15.
4
New insights into the role of the immune microenvironment in breast carcinoma.免疫微环境在乳腺癌中作用的新见解。
Clin Dev Immunol. 2013;2013:785317. doi: 10.1155/2013/785317. Epub 2013 Jun 3.
5
Constitutive activation of RANK disrupts mammary cell fate leading to tumorigenesis.RANK 的组成性激活会破坏乳腺细胞的命运,导致肿瘤发生。
Stem Cells. 2013 Sep;31(9):1954-65. doi: 10.1002/stem.1454.
6
Pretreatment levels of circulating Th1 and Th2 cytokines, and their ratios, are associated with ER-negative and triple negative breast cancers.循环 Th1 和 Th2 细胞因子及其比值的预处理水平与 ER 阴性和三阴性乳腺癌相关。
Breast Cancer Res Treat. 2013 Jun;139(2):477-88. doi: 10.1007/s10549-013-2549-3. Epub 2013 Apr 30.
7
Cytokines driving breast cancer stemness.细胞因子驱动乳腺癌干性。
Mol Cell Endocrinol. 2014 Jan 25;382(1):598-602. doi: 10.1016/j.mce.2013.03.024. Epub 2013 Apr 4.
8
Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance?肿瘤和免疫细胞的可塑性:异质性的来源和治疗抵抗的原因?
Nat Rev Cancer. 2013 May;13(5):365-76. doi: 10.1038/nrc3498. Epub 2013 Mar 28.
9
Enrichment of regulatory T cells in invasive breast tumor correlates with the upregulation of IL-17A expression and invasiveness of the tumor.浸润性乳腺癌中调节性 T 细胞的富集与 IL-17A 表达的上调和肿瘤的侵袭性相关。
Eur J Immunol. 2013 Jun;43(6):1518-28. doi: 10.1002/eji.201242951. Epub 2013 May 16.
10
Monocyte chemoattractant protein-1/CCL2 produced by stromal cells promotes lung metastasis of 4T1 murine breast cancer cells.基质细胞产生的单核细胞趋化蛋白-1/CCL2 促进 4T1 鼠乳腺癌细胞的肺转移。
PLoS One. 2013;8(3):e58791. doi: 10.1371/journal.pone.0058791. Epub 2013 Mar 18.